A 22-year-old male presents to the emergency department with a 2-day history of fever (39.5°C), severe headache, neck stiffness, and photophobia. On examination, he has a petechial rash on the trunk and lower extremities. CSF analysis shows: WBC 450/μL (90% neutrophils), protein 180 mg/dL, glucose 25 mg/dL (serum glucose 95 mg/dL), and Gram-negative diplococci are seen on Gram stain. Blood cultures are pending. Which of the following is the most appropriate initial antibiotic therapy?

Explanation

## Clinical Diagnosis **Key Point:** The clinical presentation of acute meningitis with petechial rash, CSF pleocytosis with low glucose, and Gram-negative diplococci is pathognomonic for *Neisseria meningitidis* (meningococcal meningitis). ## Why Ceftriaxone Is Correct **High-Yield:** Ceftriaxone is the current empiric first-line antibiotic for bacterial meningitis in India and globally, including meningococcal disease. It achieves excellent CSF penetration and covers the most common meningitis pathogens (*N. meningitidis*, *S. pneumoniae*, *L. monocytogenes*). **Clinical Pearl:** The dose for meningitis (2 g IV 12-hourly or 1 g IV 4–6-hourly) is higher than for non-meningitis infections to ensure adequate CSF levels. ## Comparative Antibiotic Profile | Antibiotic | CSF Penetration | *N. meningitidis* Coverage | Current Status | | --- | --- | --- | --- | | **Ceftriaxone** | Excellent (15–20%) | Excellent | **First-line** | | Penicillin G | Moderate (5–10%) | Good (if susceptible) | Outdated; resistance emerging | | Chloramphenicol | Good (40–50%) | Good | Rarely used; toxic; inferior outcomes | | Fluoroquinolone | Moderate | Adequate | Monotherapy insufficient for meningitis | ## Additional Management Points **Key Point:** Empiric therapy should be started immediately after blood cultures and CSF sampling—do not wait for culture results. Dexamethasone (10 mg IV) should be given concurrently or just before antibiotics to reduce meningeal inflammation and improve outcomes. **Mnemonic: CRAM** — **C**eftriaxone, **R**ifampicin (adjunct for resistant strains), **A**ntibiotics early, **M**eningitis protocol. ## Epidemiology & Resistance - *N. meningitidis* remains the leading cause of bacterial meningitis in young adults globally. - Penicillin resistance is now documented in many regions; cephalosporins remain reliably active. - Vaccination (MenACWY, MenB) is recommended for high-risk groups and college students in India.